Processing 00000000.tx.1: Dementia with Lewy bodies IAN G. 

Phrase: "Dementia with Lewy bodies IAN G."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.2: McKEITH, FRCPsych Department of Old Age Psychiatry, Institute for the Health of the Elderly, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK Declaration of interest None. 

Phrase: "McKEITH,"

Phrase: "FRCPsych Department of Old Age Psychiatry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   864   C0587497:Old age psychiatry department [Health Care Related Organization]
   783   C0587494:Psychiatry department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "Institute for the Health of the Elderly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]

Phrase: "Newcastle General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Westgate Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442650:Road [Manufactured Object]

Phrase: "Newcastle upon Tyne NE4 6BE,"

Phrase: "UK Declaration of interest"

Phrase: "None."
Processing 00000000.tx.3: See editorial, pp. 

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "editorial, pp."
Processing 00000000.tx.4: 9798, this issue. 

Phrase: "9798,"

Phrase: "this issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.5: ABSTRACT Background Dementia with Lewy bodies (DLB) is a common dementia subtype that has only been recognised in the past decade and that remains widely underdiagnosed. 

Phrase: "ABSTRACT Background Dementia with Lewy bodies (DLB)"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "a common dementia subtype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449560:Subtype [Classification]

Phrase: "that"

Phrase: "has"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "been"

Phrase: "recognised in the past decade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444637:Past [Temporal Concept]
   760   C2981279:Decade [Quantitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "remains"

Phrase: "widely"

Phrase: "underdiagnosed."
Processing 00000000.tx.6: Aims To review the pathological and clinical features of DLB, to consider methods of investigation and diagnosis, and to recommend safe and effective management strategies. 

Phrase: "Aims"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1947946:Aim [Idea or Concept]
  1000   C2948600:Aim [Pharmacologic Substance]
  1000   C3540471:AIM [Gene or Genome]
  1000   C3540472:AIM [Functional Concept]
  1000   C3540473:AIMS [Intellectual Product]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "the pathological"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0030664:Pathological [Biomedical Occupation or Discipline]
  1000   C1521733:Pathological [Functional Concept]
   928 E C0205469:pathology [Functional Concept]
   928 E C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "clinical features of DLB,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0205210:Clinical [Qualitative Concept]
   748   C0242821:bodies [Human]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "consider"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "methods of investigation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   756 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "diagnosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recommend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034866:recommend [Idea or Concept]

Phrase: "safe"

Phrase: "and"

Phrase: "effective management strategies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategies [Mental Process]
Processing 00000000.tx.7: Method A selective review was made of the key literature. 

Phrase: "Method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "A selective review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282443:Review [Intellectual Product]
   861   C1552617:Review [Idea or Concept]

Phrase: "was"

Phrase: "made of the key literature."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023866:Literature [Intellectual Product]
   760   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   726   C1881534:Make [Functional Concept]
Processing 00000000.tx.8: Results Using operationalised criteria, DLB can be clinically diagnosed with an accuracy similar to that achieved for Alzheimer's disease or Parkinson's disease. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "operationalised criteria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "DLB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "can"

Phrase: "be"

Phrase: "clinically"

Phrase: "diagnosed with an accuracy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011900:Diagnosed [Finding]
   770   C0443131:Accuracy [Qualitative Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "achieved for Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.9: Underdetection is largely due to poor definition of the criterion of cognitive fluctuation. 

Phrase: "Underdetection"

Phrase: "is"

Phrase: "largely due to poor definition of the criterion of cognitive fluctuation."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0678226:Due to [Functional Concept]
           due
   738   C0032854:Poor [Group Attribute]
   738   C0231239:Fluctuation [Sign or Symptom]
   738   C0231241:Fluctuation [Temporal Concept]
   738   C0243161:Criterion [Intellectual Product]
   738   C0542537:Poor [Qualitative Concept]
   738   C1516691:Cognitive [Functional Concept]
   738   C1550452:definition [Idea or Concept]
   738   C1704788:Definition [Conceptual Entity]
   738   C2700379:Poor [Qualitative Concept]
   738   C2827773:Fluctuation% [Qualitative Concept]
   738   C3146286:Due [Idea or Concept]
   738   C3539107:Definition [Intellectual Product]
Processing 00000000.tx.10: Ancillary investigations, particularly neuroimaging, can aid in differential diagnosis. 

Phrase: "Ancillary investigations,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261322:Investigations [Health Care Activity]
   827 E C1552578:investigation [Idea or Concept]
   777 E C1517586:Investigational [Qualitative Concept]
   777 E C3245491:investigational [Intellectual Product]

Phrase: "particularly neuroimaging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679575:Neuroimaging [Diagnostic Procedure]

Phrase: "can"

Phrase: "aid in differential diagnosis."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0011906:Differential Diagnosis [Diagnostic Procedure]
   833   C0220820:differential diagnosis [Functional Concept]
   819   C0597774:aid diagnosis [Diagnostic Procedure]
   770   C0011900:Diagnosis [Finding]
   770   C0018896:Aid [Social Behavior]
   770   C0443199:Differential [Qualitative Concept]
   770   C0449435:Aid [Manufactured Object]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]
   770   C1705242:Differential [Qualitative Concept]
   770   C3540469:AID [Gene or Genome]
Processing 00000000.tx.11: Extreme caution in the use of neuroleptic medication is advised. 

Phrase: "Extreme caution in the use of neuroleptic medication"

Phrase: "is"

Phrase: "advised."
Processing 00000000.tx.12: Cholinesterase inhibitors may be particularly effective in DLB. 

Phrase: "Cholinesterase inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0008425:Cholinesterase Inhibitors [Organic Chemical,Pharmacologic Substance]
  1000   C2757012:Cholinesterase Inhibitors [Molecular Function]
   966 E C3536756:Cholinesterase Inhibitor [Pharmacologic Substance]
   861   C0008429:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "particularly effective in DLB."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0242821:bodies [Human]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1280519:effective [Qualitative Concept]
   748   C1704419:Effective [Qualitative Concept]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.13: Conclusions Clinicians should be aware of DLB as part of a spectrum of Lewy body disorders. 

Phrase: "Conclusions Clinicians"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0871685:clinicians [Professional or Occupational Group]
   827 E C1550470:clinician [Idea or Concept]

Phrase: "should"

Phrase: "be"

Phrase: "aware of DLB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0004448:Aware [Mental Process]
   731   C0870212:awareness body [Mental Process]
   716   C0752347:Dementia with Lewy bodies [Disease or Syndrome]

Phrase: "as part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of a spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883073:Spectrum [Quantitative Concept]
  1000   C2827424:Spectrum [Conceptual Entity]

Phrase: "of Lewy body disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012634:Disorders [Disease or Syndrome]
   734   C0085200:Lewy Body [Cell Component]
Processing 00000000.tx.14: Neuroleptic sensitivity reactions and good response to cholinergic therapies are important aspects of management. 

Phrase: "Neuroleptic sensitivity reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "good response to cholinergic therapies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "important aspects of management."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1547011:Aspect [Quantitative Concept]
   737   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.15: Dementia with Lewy bodies (DLB) is a common form of dementia in old age, accounting for 15-20% of cases in hospital autopsy series (Weiner, 1999), a prevalence confirmed in a UK community-based dementia case register study (Holmes et al, 1999). 

Phrase: "Dementia with Lewy bodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(DLB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "is"

Phrase: "a common form of dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "in old age,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0231337:Old age [Finding]
  1000   C1999167:Old age [Population Group]
   944 E C0392079:Senile [Finding]
   861   C0001779:Age [Organism Attribute]
   861   C0580836:Old [Temporal Concept]

Phrase: "accounting for 15-20% of cases"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   783   C1631070:20/15 [Finding]
   753   C0000938:Accounting [Occupational Activity]
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1551359:account [Idea or Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]
   719 E C2741673:Account # [Clinical Attribute]
   719 E C2981730:Account [Classification]

Phrase: "in hospital autopsy series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "(Weiner,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "a prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033105:Prevalence [Quantitative Concept]
  1000   C0220900:prevalence [Quantitative Concept]

Phrase: "confirmed in a UK community-based dementia case register study"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   775   C0007328:based case study [Research Activity]
   757   C0085973:Case Study [Intellectual Product]
   739   C0009462:Community [Geographic Area]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C0521093:confirmed [Qualitative Concept]
   739   C0557651:Study [Manufactured Object]
   739   C0750484:Confirmed [Idea or Concept]
   739   C0868928:Case [Functional Concept]
   739   C1527178:Based [Functional Concept]
   739   C1705938:Based [Idea or Concept]
   739   C1706255:CASE [Medical Device]
   739   C1706256:Case [Conceptual Entity]
   739   C2603343:Study [Research Activity]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1456348:Confirm [Qualitative Concept]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(Holmes et al,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.16: The disorder shares clinical and pathological features with both Alzheimer's disease and Parkinson's disease. 

Phrase: "The disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorder [Disease or Syndrome]

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathological features with both Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.17: The differentiation of DLB from these other disorders therefore poses diagnostic difficulties  where do the boundaries begin and end? 

Phrase: "The differentiation of DLB"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0007589:Differentiation [Cell Function]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0242821:bodies [Human]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C1995017:Bodies [Cell Component]
   748   C2945687:Differentiation [Functional Concept]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "from these"

Phrase: "other disorders therefore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "poses"

Phrase: "diagnostic difficulties  where"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1299586:difficulties [Finding]
   743 E C0332218:Difficult [Qualitative Concept]

Phrase: "do"

Phrase: "the boundaries"

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "and"

Phrase: "end?"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.18: PATHOLOGY Lewy bodies are neuronal inclusions composed of abnormally phosphorylated, neurofilament proteins aggregated with ubiquitin and -synuclein. 

Phrase: "PATHOLOGY Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0085200:Lewy Bodies [Cell Component]
   827   C0242821:bodies [Human]
   827   C1995017:Bodies [Cell Component]
   793 E C0460148:Body [Anatomical Structure]
   793 E C1268086:Body [Anatomical Structure]

Phrase: "are"

Phrase: "neuronal inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "composed of abnormally"

Phrase: "phosphorylated"

Phrase: ","

Phrase: "neurofilament proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085418:Neurofilament Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "aggregated with ubiquitin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332621:Aggregated [Functional Concept]
   756 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and -"

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.19: In Parkinson's disease, Lewy body formation and neuron loss in brain-stem nuclei, particularly the substantia nigra, lead to movement disorder. 

Phrase: "In Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "Lewy body formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "and"

Phrase: "neuron loss in brain-stem nuclei,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0598940:neuron loss [Finding]
   754 E C1850496:Neuronal loss [Finding]
   753   C1517945:Loss [Quantitative Concept]

Phrase: "particularly"

Phrase: "the substantia nigra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "lead to movement disorder."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0026650:Movement disorder [Disease or Syndrome]
   770   C0012634:Disorder [Disease or Syndrome]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0026649:Movement [Organism Function]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.20: In DLB, significant Lewy body formation also occurs in paralimbic and neocortical structures, and extensive depletion of acetylcholine neurotransmission in neocortical areas occurs as a result of degeneration in the brain-stem and basal forebrain cholinergic projection neurons. 

Phrase: "In DLB,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   937   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0150312:In [Quantitative Concept]
   804   C0242821:bodies [Human]
   804   C0332285:In [Spatial Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "significant Lewy body formation also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]

Phrase: "occurs in paralimbic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "neocortical structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "extensive depletion of acetylcholine neurotransmission"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333668:Depletion [Functional Concept]

Phrase: "in neocortical areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "occurs as a result of degeneration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0011164:Degeneration [Pathologic Function]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1709305:Occur [Activity]
   753   C1880269:Degeneration [Functional Concept]
   753   C2745955:OCCUR [Temporal Concept]
   753   C2825142:Result [Finding]

Phrase: "in the brain-stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "basal forebrain cholinergic projection neurons."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   853   C2333949:Cholinergic Neurons [Cell]
   806   C0682698:Projection neuron [Cell]
   804   C0016538:Projection [Intellectual Product]
   804   C0027882:Neurons [Cell]
   804   C0033363:Projection [Mental Process]
   804   C0348018:Projection [Spatial Concept]
   721 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.21: A distinctive pattern of ubiquitin and -synuclein immunoreactive neuritic degeneration has additionally been identified in DLB. 

Phrase: "A distinctive pattern of ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "and -"

Phrase: "synuclein immunoreactive neuritic degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011164:Degeneration [Pathologic Function]
   812   C1880269:Degeneration [Functional Concept]

Phrase: "has"

Phrase: "additionally"

Phrase: "been"

Phrase: "identified in DLB."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   790   C0085200:Lewy Bodies [Cell Component]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0205396:Identified [Qualitative Concept]
   753   C0242821:bodies [Human]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1995017:Bodies [Cell Component]
   719 E C0460148:Body [Anatomical Structure]
   719 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.22: Lewy neurites are seen in the substantia nigra, hippocampal region CA2/3, dorsal vagal nucleus, basal nucleus of Meynert and transentorhinal cortex. 

Phrase: "Lewy neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C3548404:Lewy neurite [Cell Component]
   861   C0085103:Neurites [Cell Component]

Phrase: "are"

Phrase: "seen in the substantia nigra,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   806   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   760   C0205397:Seen [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "hippocampal region CA2/3,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C3496509:hippocampal region [Body Location or Region]
   812   C0017446:Region [Geographic Area]
   812   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   812   C0205147:Region [Spatial Concept]
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "dorsal vagal nucleus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007610:Nucleus [Cell Component]
   827   C0205095:Dorsal [Spatial Concept]

Phrase: "basal nucleus of Meynert"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0004788:Basal Nucleus of Meynert [Body Part, Organ, or Organ Component]
           basal nucleus
   861   C0004781:Basal nucleus [Body Part, Organ, or Organ Component]
   861   C1321510:Basal nucleus [Body Part, Organ, or Organ Component]
   812   C0007610:Nucleus [Cell Component]
   812   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "transentorhinal cortex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]
Processing 00000000.tx.23: These extensive neuritic changes are probably more relevant for neuropsychiatric symptom formation than the relatively sparsely distributed cortical Lewy bodies (Gmez-Tortosa et al, 1999). 

Phrase: "These extensive neuritic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "probably more relevant for neuropsychiatric symptom formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevant [Qualitative Concept]

Phrase: "than the relatively sparsely"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "cortical Lewy bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   983   C3548436:cortical Lewy body [Cell Component]
   901   C0085200:Lewy Bodies [Cell Component]
   827   C0242821:bodies [Human]
   827   C1995017:Bodies [Cell Component]
   793 E C0460148:Body [Anatomical Structure]
   793 E C1268086:Body [Anatomical Structure]

Phrase: "(Gmez-Tortosa et al,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.24: Some Alzheimer-type changes are also present in the majority of patients with DLB. 

Phrase: "Some Alzheimer-type changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "also"

Phrase: "present in the majority of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
   753   C0680220:majority [Social Behavior]

Phrase: "with DLB."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   888   C0752347:dementia lewy bodies [Disease or Syndrome]
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0242821:bodies [Human]
   804   C0332287:With [Qualitative Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1705690:With [Intellectual Product]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.25: Senile plaques, diffuse and neuritic, are present in similar density and distribution as in Alzheimer's disease, but the other hallmark lesions of Alzheimer's disease, neurofibrillary tangles, are relatively few (Weiner, 1999), as are biochemical measures of tau pathology. 

Phrase: "Senile plaques,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "and"

Phrase: "neuritic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0027813:Neuritides [Disease or Syndrome]

Phrase: "are"

Phrase: "present in similar density"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "as in Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "but"

Phrase: "the other hallmark"

Phrase: "lesions of Alzheimer's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0221198:Lesion [Finding]
   770   C1546698:Lesion [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "neurofibrillary tangles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "relatively few"

Phrase: "(Weiner,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "are"

Phrase: "biochemical measures of tau pathology."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0079809:Measures [Quantitative Concept]
   760   C1879489:Measures [Functional Concept]
   726 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.26: Stringent neuropathological criteria for Alzheimer's disease require above-threshold numbers of neocortical neurofibrillary tangles. 

Phrase: "Stringent neuropathological criteria for Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243161:criteria [Intellectual Product]

Phrase: "require"

Phrase: "above-threshold numbers of neocortical neurofibrillary tangles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.27: Therefore, most DLB cases should probably be regarded as distinct from Alzheimer's disease and not as a variant of it. 

Phrase: "Therefore,"

Phrase: "most DLB cases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "should"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "be"

Phrase: "regarded as distinct"

Phrase: "from Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "not as a variant of it."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205419:Variant [Qualitative Concept]
   753   C1518422:Not [Functional Concept]
Processing 00000000.tx.28: Minor vascular disease also occurs in about 30%, but its clinical significance is unknown. 

Phrase: "Minor vascular disease also"
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   861   C0042373:Vascular disease [Disease or Syndrome]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0012634:Disease [Disease or Syndrome]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   811 E C0018939:Blood disease NOS [Disease or Syndrome]
   811 E C1533163:Blood disease [Disease or Syndrome]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "occurs in about 30%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "but"

Phrase: "its clinical significance"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2826293:Clinical Significance [Finding]
   861   C0237881:Significance [Quantitative Concept]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.29: Mixed pathological changes are therefore usually seen in DLB (Holmes et al, 1999), cases of pure DLB without any plaques, tangles or vascular lesions being uncommon. 

Phrase: "Mixed pathological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "therefore usually"

Phrase: "seen in DLB"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   790   C0085200:Lewy Bodies [Cell Component]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0205397:Seen [Qualitative Concept]
   753   C0242821:bodies [Human]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C1995017:Bodies [Cell Component]
   719 E C0042789:see [Organism Function]
   719 E C0460148:Body [Anatomical Structure]
   719 E C1268086:Body [Anatomical Structure]
   719 E C1947903:See [Activity]

Phrase: "(Holmes et al,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "cases of pure DLB"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "without any plaques,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "tangles"

Phrase: "or"

Phrase: "vascular lesions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1402315:Vascular lesions [Disease or Syndrome]
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "being"

Phrase: "uncommon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522498:Uncommon [Qualitative Concept]
Processing 00000000.tx.30: CLINICAL FEATURES Dementia is usually, but not always, the presenting feature  a minority of patients present with parkinsonism alone, some with psychiatric disorder in the absence of dementia, and others with orthostatic hypotension, falls or transient disturbances of consciousness (Byrne et al, 1989; McKeith et al, 1992) (Table 1). 

Phrase: "CLINICAL FEATURES Dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "usually,"

Phrase: "but"

Phrase: "not always,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C2003902:Always [Temporal Concept]

Phrase: "the presenting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presenting [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "a minority of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026192:Minority [Population Group]

Phrase: "present with parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0150312:Present [Quantitative Concept]
   790   C0242422:Parkinsonism [Disease or Syndrome]
   790   C0449450:Present [Idea or Concept]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "some with psychiatric disorder"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0004936:Psychiatric disorder [Mental or Behavioral Dysfunction]
   770   C0012634:Disorder [Disease or Syndrome]
   770   C0205392:Some [Quantitative Concept]
   770   C0205487:Psychiatric [Functional Concept]
   770   C3540770:Some [Intellectual Product]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of dementia,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "others with orthostatic hypotension,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0348663:Other hypotension [Pathologic Function]
   770   C1955473:Others [Finding]
   737 E C0205394:Other [Qualitative Concept]

Phrase: "falls"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085639:Falls [Finding]
   966 E C0238715:Fall [Temporal Concept]

Phrase: "or"

Phrase: "transient disturbances of consciousness"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0234428:Disturbances of consciousness [Sign or Symptom]
           consciousness disturbance
   737   C2699787:Disturbance [Qualitative Concept]

Phrase: "(Byrne et al,"

Phrase: "1989"

Phrase: "; McKeith et al,"

Phrase: "1992"

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.31: View this table: [in this window] [in a new window]  Table 1 A comparison of clinical symptoms in Alzheimer's disease and dementia with Lewy bodies  Age at onset ranges from 50 to 83 years and at death from 68 to 92 years, with a slight excess of males. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "A comparison of clinical symptoms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "dementia with Lewy bodies  Age at onset"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "ranges from 50"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1514721:*Ranges [Quantitative Concept]
   790   C2348147:Range [Quantitative Concept]
   790   C3542016:Range [Intellectual Product]

Phrase: "to 83 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and at death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011065:Death [Organism Function]
   790   C1306577:Death, NOS [Finding]
   790   C1515981:And [Idea or Concept]

Phrase: "from 68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "to 92 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "with a slight excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979886:Excess [Qualitative Concept]

Phrase: "of males."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]
Processing 00000000.tx.32: Mean survival time is similar to that for Alzheimer's disease, although some DLB patients show rapid symptom progression and death within 1-2 years of onset. 

Phrase: "Mean survival time"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0086595:Mean Survival Time [Quantitative Concept]
   901   C2919552:Survival time [Clinical Attribute]
   827   C0038952:Survival [Activity]
   827   C0040223:Time [Temporal Concept]
   827   C0220921:survival [Functional Concept]
   827   C0444504:Mean [Quantitative Concept]
   827   C2347634:Mean [Quantitative Concept]
   827   C2348143:Mean [Quantitative Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "is"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "for Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "although"

Phrase: "some DLB patients"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "rapid symptom progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1838681:Rapid progression [Finding]
   827   C0242656:progression [Pathologic Function]
   827   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "death within 1-2 years of onset."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011065:Death [Organism Function]
   748   C1306577:Death, NOS [Finding]
Processing 00000000.tx.33: Cognitive function appears to worsen at the same rate as in Alzheimer's disease, and parkinsonism at a rate similar to that in Parkinson's disease: approximately 10% decline per year for each. 

Phrase: "Cognitive function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0392335:cognitive function [Mental Process]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1516691:Cognitive [Functional Concept]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "worsen at the same rate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332271:worsen [Qualitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C0871208:Rate [Activity]
   760   C1279889:worsen [Finding]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "as in Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "parkinsonism at a rate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: ":"

Phrase: "approximately 10% decline per year"

Phrase: "for each."
Processing 00000000.tx.34: Fluctuation in cognitive performance and level of consciousness is the most characteristic feature of DLB. 

Phrase: "Fluctuation in cognitive performance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0231239:Fluctuation [Sign or Symptom]
   770   C0231241:Fluctuation [Temporal Concept]
   770   C2827773:Fluctuation% [Qualitative Concept]

Phrase: "and"

Phrase: "level of consciousness"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0234425:Level of consciousness [Finding]
   822   C0456384:Conscious level [Qualitative Concept]
   790   C0441889:Level [Qualitative Concept]
   790   C0456079:Level [Classification]
   790   C1547707:Level [Geographic Area]
   790   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "the most characteristic feature of DLB."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   818   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   767 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   764   C0085200:Lewy Bodies [Cell Component]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0242821:bodies [Human]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]
   742   C1521970:Characteristic [Qualitative Concept]
           Feature
   742   C1706388:Feature [Conceptual Entity]
   742   C1995017:Bodies [Cell Component]
   742   C2346469:Feature [Qualitative Concept]
   742   C2348519:Feature [Qualitative Concept]
   708 E C0460148:Body [Anatomical Structure]
   708 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.35: It is usually evident on a day-to-day basis, and often apparent within much shorter periods. 

Phrase: "It"

Phrase: "is"

Phrase: "usually evident on a day-to-day basis,"

Phrase: "and"

Phrase: "often apparent within much shorter periods."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.36: The marked amplitude between best and worst performance distinguishes it from the minor day-to-day variations that commonly occur in dementia of any cause. 

Phrase: "The marked amplitude between best"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "and"

Phrase: "worst performance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597198:Performance [Individual Behavior]
   861   C1882330:Performance [Activity]

Phrase: "distinguishes"

Phrase: "it from the minor day-to-day variations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0026193:Minor [Population Group]
   744   C0205165:Minor [Qualitative Concept]
   744   C0205419:variations [Qualitative Concept]
   744   C0332173:/day [Temporal Concept]
   744   C0439228:day [Temporal Concept]
   744   C0439505:/day [Temporal Concept]

Phrase: "that commonly"

Phrase: "occur in dementia of any cause."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0015127:cause [Functional Concept]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C1524003:Cause [Conceptual Entity]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.37: About two-thirds of patients report visual hallucinations, repeatedly seeing people and animals that appear to be real but make no noise. 

Phrase: "About two-thirds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205437:Third [Quantitative Concept]
   861   C0205448:Two [Quantitative Concept]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "visual hallucinations,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0233763:Hallucinations, Visual [Sign or Symptom]
   861   C0018524:Hallucinations [Mental or Behavioral Dysfunction]
   861   C0234621:Visual [Functional Concept]

Phrase: "repeatedly seeing people"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027361:People [Population Group]

Phrase: "and"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "that"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "real"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237400:Real [Qualitative Concept]
  1000   C3272377:REAL [Intellectual Product]

Phrase: "but"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "no noise."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028263:Noise [Phenomenon or Process]
Processing 00000000.tx.38: Emotional responses to these experiences vary from intense fear to indifference or even amusement. 

Phrase: "Emotional responses to these experiences"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   806   C0870485:emotional responses [Mental Process]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "vary from intense fear"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015726:Fear [Mental Process]
   770   C0522510:Intense [Qualitative Concept]

Phrase: "to indifference"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085632:Indifference [Sign or Symptom]
   928 E C0332238:Indifferent [Qualitative Concept]

Phrase: "or"

Phrase: "even amusement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680153:amusement [Daily or Recreational Activity]
Processing 00000000.tx.39: Depressive symptoms are common and 40% of patients have a major depressive episode, similar to the rate in Parkinson's disease and significantly greater than in Alzheimer's disease. 

Phrase: "Depressive symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086132:Depressive Symptoms [Sign or Symptom]
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "are"

Phrase: "common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "40% of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0439509:/40 [Temporal Concept]

Phrase: "have"

Phrase: "a major depressive episode,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024517:major depressive episode [Mental or Behavioral Dysfunction]
   901   C0011581:Depressive episode [Mental or Behavioral Dysfunction]
   901   C0349217:depressive episode [Mental or Behavioral Dysfunction]
   827   C0205164:Major [Qualitative Concept]
   827   C0332189:Episode [Temporal Concept]

Phrase: "similar to the rate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "in Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "significantly greater than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.40: Up to 70% of patients have parkinsonism; 

Phrase: "Up to 70%"

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.41: bradykinesia, limb rigidity and gait disorder are the most common manifestations. 

Phrase: "bradykinesia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]

Phrase: "limb rigidity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0858572:Limb rigidity [Sign or Symptom]
   861   C0026837:Rigidity, NOS [Sign or Symptom]
   861   C0700109:rigidity [Natural Phenomenon or Process]
   789 E C0231517:Rigid [Individual Behavior]
   789 E C1882952:RIGID [Phenomenon or Process]

Phrase: "and"

Phrase: "gait disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0575081:Gait disorder [Sign or Symptom]
   861   C0012634:Disorder [Disease or Syndrome]

Phrase: "are"

Phrase: "the most common manifestations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205319:manifestations [Functional Concept]
   827   C1280464:manifestations [Qualitative Concept]
Processing 00000000.tx.42: When present, these symptoms may be as severe in DLB as in Parkinson's disease. 

Phrase: "When"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "these symptoms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683368:symptoms [Functional Concept]
  1000   C1457887:Symptoms [Sign or Symptom]

Phrase: "may"

Phrase: "be"

Phrase: "as"

Phrase: "severe in DLB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C3494652:Severe dementia [Mental or Behavioral Dysfunction]
   753   C0205082:Severe [Qualitative Concept]
   716   C0752347:Dementia with Lewy bodies [Disease or Syndrome]

Phrase: "as in Parkinson's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.43: Recurrent falls and syncope occur in up to a third, presumably reflecting autonomic nervous system involvement. 

Phrase: "Recurrent falls"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0458990:Recurrent falls [Finding]
   861   C0085639:Falls [Finding]
   827 E C0238715:Fall [Temporal Concept]

Phrase: "and"

Phrase: "syncope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039070:Syncope [Sign or Symptom]
  1000   C3541349:Syncope [Amphibian]

Phrase: "occur in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1709305:Occur [Activity]
   833   C2745955:OCCUR [Temporal Concept]

Phrase: "up to a third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "presumably"

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "autonomic nervous system involvement."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0238714:AUTONOMIC SYSTEM INVOLVEMENT [Finding]
   902   C3553789:Autonomic involvement [Finding]
   812   C1314939:Involvement [Functional Concept]
   756   C0004388:Autonomic nervous system [Body System]
Processing 00000000.tx.44: Transient disturbances of consciousness in which patients are found mute and unresponsive for periods of several minutes may represent the extreme of fluctuation in attention and arousal, but are often mistaken for transient ischaemic attacks, despite a lack of focal neurological signs. 

Phrase: "Transient disturbances of consciousness"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0234428:Disturbances of consciousness [Sign or Symptom]
           consciousness disturbance
   737   C2699787:Disturbance [Qualitative Concept]

Phrase: "in which patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "are"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "mute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0278249:Mute [Finding]

Phrase: "and"

Phrase: "unresponsive for periods of several minutes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205269:Unresponsive [Functional Concept]
   753   C0237284:Unresponsive [Finding]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the extreme of fluctuation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205403:Extreme [Qualitative Concept]

Phrase: "in attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004268:Attention [Mental Process]

Phrase: "and"

Phrase: "arousal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003808:Arousal [Mental Process]

Phrase: "but"

Phrase: "are"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "mistaken for transient ischaemic attacks,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0007787:Transient ischaemic attacks [Disease or Syndrome]
   790   C0745413:ischemic attack [Disease or Syndrome]
   760   C0040704:Transient [Population Group]
   760   C0205374:Transient [Temporal Concept]
   760   C0475224:Ischaemic [Functional Concept]
   760   C1261512:attacks [Social Behavior]
   760   C1304680:attacks [Finding]
   726 E C0277793:Attack, NOS [Temporal Concept]
   726   C0743559:mistake [Qualitative Concept]

Phrase: "despite a lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "of focal neurological signs."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0220912:signs [Functional Concept]
   827   C0220913:signs [Manufactured Object]
   827   C0311392:SIGNS [Finding]
   793 E C1547188:Sign [Idea or Concept]
Processing 00000000.tx.45: DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS There are four main categories of disorder that should be considered in the differential diagnosis of DLB. 

Phrase: "DIAGNOSIS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "AND"

Phrase: "DIFFERENTIAL DIAGNOSIS There"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0011906:Differential Diagnosis [Diagnostic Procedure]
   901   C0220820:differential diagnosis [Functional Concept]
   827   C0011900:Diagnosis [Finding]
   827   C0443199:Differential [Qualitative Concept]
   827   C1704338:diagnosis [Qualitative Concept]
   827   C1704656:DIAGNOSIS [Research Activity]
   827   C1705242:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "four main categories of disorder"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0683312:Categories [Intellectual Product]
   726 E C1555713:category [Idea or Concept]

Phrase: "that"

Phrase: "should"

Phrase: "be"

Phrase: "considered in the differential diagnosis of DLB."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   806   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   761 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0011906:Differential Diagnosis [Diagnostic Procedure]
   760   C0085200:Lewy Bodies [Cell Component]
   760   C0220820:differential diagnosis [Functional Concept]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0011900:Diagnosis [Finding]
   739   C0242821:bodies [Human]
   739   C0443199:Differential [Qualitative Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C0750591:considered [Idea or Concept]
   739   C1704338:diagnosis [Qualitative Concept]
   739   C1704656:DIAGNOSIS [Research Activity]
   739   C1705242:Differential [Qualitative Concept]
   739   C1995017:Bodies [Cell Component]
   706 E C0460148:Body [Anatomical Structure]
   706 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.46: These are other dementia syndromes; 

Phrase: "These"

Phrase: "are"

Phrase: "other dementia syndromes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0039082:Syndromes [Disease or Syndrome]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558916:SYNDROMES [Finding]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.47: other causes of delirium; 

Phrase: "other causes of delirium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015127:causes [Functional Concept]
   770   C1314792:Causes [Functional Concept]
   737 E C1524003:Cause [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.48: other neurological syndromes such as Parkinson's disease, progressive supranuclear palsy, multi-system atrophy or CreutzfeldtJakob disease; 

Phrase: "other neurological syndromes such as Parkinson's disease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0030567:PARKINSON'S SYNDROME [Disease or Syndrome]
   748   C0039082:Syndromes [Disease or Syndrome]
   748   C1558916:SYNDROMES [Finding]

Phrase: "progressive supranuclear palsy,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "multi-system atrophy"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multi [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "or"

Phrase: "CreutzfeldtJakob disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.49: and other psychiatric disorders such as late-onset delusional disorder, depressive psychosis and mania. 

Phrase: "and"

Phrase: "other psychiatric disorders such as late-onset delusional disorder,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   784   C0376415:Late-Onset Disorders [Disease or Syndrome]
   764   C0004936:Psychiatric disorders [Mental or Behavioral Dysfunction]
   762   C0011251:DELUSIONAL DISORDERS [Mental or Behavioral Dysfunction]
   745   C0277793:Disorder Onset [Temporal Concept]
   742   C0012634:Disorders [Disease or Syndrome]
   742   C0205487:Psychiatric [Functional Concept]

Phrase: "depressive psychosis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0743072:depressive psychosis [Mental or Behavioral Dysfunction]
   861   C0033975:Psychosis [Mental or Behavioral Dysfunction]
   861   C0349204:Psychosis NOS [Mental or Behavioral Dysfunction]
   789 E C0459435:Psychotic [Finding]

Phrase: "and"

Phrase: "mania."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0338831:Mania [Mental or Behavioral Dysfunction]
   928 E C0564408:Manic [Finding]
Processing 00000000.tx.50: The most frequent clinical misdiagnosis of DLB is as Alzheimer's disease. 

Phrase: "The most frequent clinical misdiagnosis of DLB"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   761 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0085200:Lewy Bodies [Cell Component]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0205210:Clinical [Qualitative Concept]
   739   C0242821:bodies [Human]
   739   C0332183:Frequent [Temporal Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C0679838:Misdiagnosis [Finding]
   739   C1995017:Bodies [Cell Component]
   706 E C0460148:Body [Anatomical Structure]
   706 E C1268086:Body [Anatomical Structure]

Phrase: "is as Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.51: Accurate diagnosis rests upon careful history-taking and physical and mental state examinations. 

Phrase: "Accurate diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011900:Diagnosis [Finding]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "rests upon careful history-taking"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0199182:History taking [Health Care Activity]
   760   C0019664:History [Occupation or Discipline]
   760   C0019665:history [Intellectual Product]
   760   C0035253:Rest [Daily or Recreational Activity]
   760   C0262512:History, NOS [Organism Attribute]
   760   C0262926:History [Finding]
   760   C1622890:ResT [Molecular Function]
   760   C1705255:History [Conceptual Entity]
   760   C2004062:History [Finding]
   726   C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "physical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031809:Physical [Health Care Activity]
  1000   C0205485:Physical [Functional Concept]
  1000   C1509143:Physical [Finding]

Phrase: "and"

Phrase: "mental state examinations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0850338:mental state examination [Therapeutic or Preventive Procedure]
   827   C0031809:examinations [Health Care Activity]
   734   C0278060:Mental state [Finding]
Processing 00000000.tx.52: Although no specific biological test or marker is available, clinical investigations may be helpful (Table 2). 

Phrase: "Although"

Phrase: "no specific biological test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0205460:biological [Qualitative Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "or"

Phrase: "marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "is"

Phrase: "available, clinical investigations"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1261322:Clinical investigation [Health Care Activity]
           Investigations
   793 E C1552578:investigation [Idea or Concept]
   743 E C1517586:Investigational [Qualitative Concept]
   743 E C3245491:investigational [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "helpful"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0018896:Help [Social Behavior]
   928   C1552861:help [Idea or Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.53: View this table: [in this window] [in a new window]  Table 2 The role of clinical investigations in discriminating Alzheimer's disease and dementia with Lewy bodies  Structural brain imaging in DLB reveals generalised atrophy, although 40% of patients show preservation of medial temporal lobe structures, unlike Alzheimer's disease. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "The role of clinical investigations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in discriminating Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "dementia with Lewy bodies  Structural brain"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "imaging in DLB"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   790   C0085200:Lewy Bodies [Cell Component]
   767   C0005891:bodies image [Mental Process]
   767   C1555874:Body Imaging [Professional or Occupational Group]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0011923:Imaging [Diagnostic Procedure]
   753   C0079595:Imaging [Diagnostic Procedure]
   753   C0242821:bodies [Human]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C1995017:Bodies [Cell Component]
   719 E C0460148:Body [Anatomical Structure]
   719 E C1268086:Body [Anatomical Structure]
   719 E C1704254:Image [Intellectual Product]
   719 E C1704922:Image [Entity]
   719 E C3542466:Image [Intellectual Product]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "generalised atrophy,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "although"

Phrase: "40% of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0439509:/40 [Temporal Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "preservation of medial temporal lobe structures,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033085:Preservation [Laboratory Procedure]
   753   C1514402:Preservation [Laboratory Procedure]

Phrase: "unlike Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.54: There is no difference from Alzheimer's disease in terms of degree of ventricular enlargement, frontal lobe atrophy or presence of white-matter changes on magnetic resonance imaging (Barber et al, 1999). 

Phrase: "There"

Phrase: "is"

Phrase: "no difference from Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "in terms of degree"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0441889:Degree [Qualitative Concept]
  1000   C0449286:Degree [Quantitative Concept]
  1000   C0542560:Degree [Intellectual Product]
  1000   C1561545:degree [Quantitative Concept]
  1000   C2348088:Degree [Quantitative Concept]

Phrase: "of ventricular enlargement,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2675972:Ventricular enlargement [Finding]
   861   C0020564:Enlargement, NOS [Pathologic Function]
   861   C1293134:Enlargement [Therapeutic or Preventive Procedure]
   861   C2711450:Enlargement [Anatomical Abnormality]

Phrase: "frontal lobe atrophy"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3279888:Frontal lobe atrophy [Finding]
   865   C0333667:Lobar atrophy [Pathologic Function]
   827   C0333641:Atrophy [Pathologic Function]
   755 E C0151514:Atrophic [Disease or Syndrome]
   734   C0016733:frontal lobe [Body Part, Organ, or Organ Component]
   734   C1268977:Frontal lobe [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "presence of white-matter changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "on magnetic resonance imaging"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0024485:Magnetic Resonance Imaging [Diagnostic Procedure]
  1000   C1552358:Magnetic Resonance Imaging [Professional or Occupational Group]
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0011923:Imaging [Diagnostic Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0079595:Imaging [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   793 E C1704254:Image [Intellectual Product]
   793 E C1704922:Image [Entity]
   793 E C3542466:Image [Intellectual Product]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "(Barber et al,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.55: Using single-photon emission computed tomography (SPECT), significant reduction in striatal uptake of a ligand for the presynaptic dopamine transporter site (FP-CIT) is seen in DLB but not in Alzheimer's disease, and this may prove to be a highly specific and widely applicable diagnostic test (Walker et al, 1999). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "single-photon emission computed tomography (SPECT),"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0040399:Tomography, Emission-Computed, Single-Photon [Diagnostic Procedure]
           Single Photon Emission Tomography
   884   C0040398:Tomography, Emission-Computed [Diagnostic Procedure]
   840   C0040405:computed tomography [Diagnostic Procedure]
           tomography
   840   C1552357:Computed Tomography [Professional or Occupational Group]
   804   C0037179:Single [Population Group]
   804   C0040395:tomography [Diagnostic Procedure]
   804   C0086805:Photon [Substance]
   804   C0087136:single [Finding]
   804   C0205171:Single [Quantitative Concept]
   804   C0233929:Emission [Body Substance]
   804   C1441526:Computed [Laboratory Procedure]
   804   C1880157:Computed [Activity]
   804   C2349995:Emission [Substance]

Phrase: "significant reduction in striatal uptake of a ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "for the presynaptic dopamine transporter site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "(FP-CIT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0255374:FP-CIT [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "is"

Phrase: "seen in DLB"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   790   C0085200:Lewy Bodies [Cell Component]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0205397:Seen [Qualitative Concept]
   753   C0242821:bodies [Human]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C1995017:Bodies [Cell Component]
   719 E C0042789:see [Organism Function]
   719 E C0460148:Body [Anatomical Structure]
   719 E C1268086:Body [Anatomical Structure]
   719 E C1947903:See [Activity]

Phrase: "but"

Phrase: "not in Alzheimer's disease,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1518422:Not [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "this"

Phrase: "may"

Phrase: "prove"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a highly specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "widely applicable diagnostic test"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0086143:diagnostic test [Diagnostic Procedure]
   861   C0430022:Diagnostic Test [Diagnostic Procedure]
   819 E C1263440:diagnostic tests [Medical Device]
   812   C0011900:Diagnostic [Finding]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0348026:Diagnostic [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "(Walker et al,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.56: The consensus criteria for the clinical diagnosis of DLB are given in the Appendix (McKeith et al, 1996). 

Phrase: "The consensus criteria for the clinical diagnosis of DLB"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   790   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   753   C0085200:Lewy Bodies [Cell Component]
   753   C0332140:Diagnosis, clinical [Qualitative Concept]
   751 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   736   C0011265:dementia [Mental or Behavioral Dysfunction]
   736   C0011900:Diagnosis [Finding]
   736   C0205210:Clinical [Qualitative Concept]
   736   C0242821:bodies [Human]
   736   C0243161:criteria [Intellectual Product]
   736   C0376298:Consensus [Social Behavior]
   736   C0497327:Dementia [Mental or Behavioral Dysfunction]
   736   C1704338:diagnosis [Qualitative Concept]
   736   C1704656:DIAGNOSIS [Research Activity]
   736   C1995017:Bodies [Cell Component]
   703 E C0460148:Body [Anatomical Structure]
   703 E C1268086:Body [Anatomical Structure]

Phrase: "are"

Phrase: "given in the Appendix"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0003617:Appendix [Body Part, Organ, or Organ Component]
   770   C1269000:Appendix [Body Part, Organ, or Organ Component]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]

Phrase: "(McKeith et al,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.57: Particular emphasis needs to be given to recognising the characteristic pattern of cognitive dysfunction with prominent attentional deficits, visuospatial impairment and frontosubcortical dysfunction. 

Phrase: "Particular emphasis"

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "given to recognising"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: "the characteristic pattern of cognitive dysfunction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "with prominent attentional deficits,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   865   C0041671:Attention deficits [Mental or Behavioral Dysfunction]
   827   C2987487:deficits [Qualitative Concept]
   793 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "visuospatial impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0684336:Impairment [Pathologic Function]

Phrase: "and"

Phrase: "frontosubcortical dysfunction."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.58: In contrast to Alzheimer's disease there is often a relative preservation of short-term memory. 

Phrase: "In contrast to Alzheimer's disease there"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "a relative preservation of short-term memory."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0033085:Preservation [Laboratory Procedure]
   748   C1514402:Preservation [Laboratory Procedure]
Processing 00000000.tx.59: Probable DLB is diagnosed if any two of the three core symptoms (fluctuating cognition, visual hallucinations, spontaneous motor features of parkinsonism) are additionally present. 

Phrase: "Probable DLB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   926   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   827 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "if"

Phrase: "any two of the three core symptoms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205448:Two [Quantitative Concept]

Phrase: "(fluctuating cognition,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0009240:Cognition [Mental Process]
   777 E C2981149:Intellect [Mental Process]
   768 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "visual hallucinations,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0233763:Hallucinations, Visual [Sign or Symptom]
   861   C0018524:Hallucinations [Mental or Behavioral Dysfunction]
   861   C0234621:Visual [Functional Concept]

Phrase: "spontaneous motor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1513492:Motor [Functional Concept]
   861   C1705994:Motor [Manufactured Object]

Phrase: "features of parkinsonism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0242422:Parkinsonism [Disease or Syndrome]
   790   C1521970:Feature [Qualitative Concept]
   790   C1706388:Feature [Conceptual Entity]
   790   C2346469:Feature [Qualitative Concept]
   790   C2348519:Feature [Qualitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "additionally"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.60: Several autopsy validation studies have examined the diagnostic accuracy of the consensus criteria and find uniformly high specificity, usually 0.9-1.0, but sensitivity of case detection is more variable and generally lower (0.22-0.83). 

Phrase: "Several autopsy validation studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0681836:Validation Studies [Intellectual Product,Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   812   C1519941:Validation [Research Activity]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the diagnostic accuracy of the consensus criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0598285:Diagnostic Accuracy [Qualitative Concept]
   748   C0443131:Accuracy [Qualitative Concept]

Phrase: "and"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "uniformly high specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "usually 0.9-1.0,"

Phrase: "but"

Phrase: "sensitivity of case detection"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C2347565:Case Sensitivity [Qualitative Concept]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "is"

Phrase: "more variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "and"

Phrase: "generally lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]

Phrase: "(0.22-0.83"

Phrase: ")."
Processing 00000000.tx.61: Identifying cognitive fluctuation poses clinicians the greatest diagnostic difficulty. 

Phrase: "Identifying"

Phrase: "cognitive fluctuation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0231239:Fluctuation [Sign or Symptom]
   861   C0231241:Fluctuation [Temporal Concept]
   861   C2827773:Fluctuation% [Qualitative Concept]

Phrase: "poses"

Phrase: "clinicians"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871685:clinicians [Professional or Occupational Group]
   966 E C1550470:clinician [Idea or Concept]

Phrase: "the greatest diagnostic difficulty."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1299586:Difficulty [Finding]
   755 E C0332218:Difficult [Qualitative Concept]
Processing 00000000.tx.62: Standardised methods for quantifying fluctuation in dementia have now been published. 

Phrase: "Standardised methods for quantifying fluctuation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "in dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "been"

Phrase: "published."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]
Processing 00000000.tx.63: The Clinician Assessment of Fluctuation is a clinician-administered severity scale, and the One Day Fluctuation Assessment Scale is based on a caregiver questionnaire. 

Phrase: "The Clinician Assessment of Fluctuation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "is"

Phrase: "a clinician-administered severity scale,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0175659:Scale [Medical Device]
   812   C0349674:Scale [Intellectual Product]
   812   C1947916:Scale [Activity]
   812   C3536777:Scale [Manufactured Object]
   741 E C1710017:Scalar [Qualitative Concept]
   729 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the One Day Fluctuation Assessment Scale"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C0450973:assessment scale [Intellectual Product]
   804   C0175659:Scale [Medical Device]
   804   C0349674:Scale [Intellectual Product]
   804   C1947916:Scale [Activity]
   804   C3536777:Scale [Manufactured Object]
   733 E C1710017:Scalar [Qualitative Concept]
   721 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "based on a caregiver questionnaire."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0034394:Questionnaire [Intellectual Product]
   760   C0085537:Caregiver [Professional or Occupational Group]
   760   C1527178:Based [Functional Concept]
   760   C1546494:Care giver [Idea or Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.64: If independently confirmed, these methods have the potential to significantly increase the reliability  and therefore the validity  of a diagnosis of DLB (Walker et al, 2000). 

Phrase: "If"

Phrase: "independently"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: ","

Phrase: "these methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "have"

Phrase: "the potential to significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3245505:Potential [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the reliability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347947:Reliability [Quantitative Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "the validity  of a diagnosis of DLB"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   761 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0085200:Lewy Bodies [Cell Component]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0011900:Diagnosis [Finding]
   739   C0242821:bodies [Human]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C1704338:diagnosis [Qualitative Concept]
   739   C1704656:DIAGNOSIS [Research Activity]
   739   C1995017:Bodies [Cell Component]
   739   C2349101:Validity [Quantitative Concept]
   706 E C0460148:Body [Anatomical Structure]
   706 E C1268086:Body [Anatomical Structure]

Phrase: "(Walker et al,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.65: MANAGEMENT Antipsychotic pharmacotherapy Managing psychosis is one of the most difficult challenges in the care of patients with DLB. 

Phrase: "MANAGEMENT Antipsychotic pharmacotherapy Managing psychosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0033975:Psychosis [Mental or Behavioral Dysfunction]
   804   C0349204:Psychosis NOS [Mental or Behavioral Dysfunction]
   733 E C0459435:Psychotic [Finding]

Phrase: "is"

Phrase: "one of the most difficult challenges"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "in the care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with DLB."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   888   C0752347:dementia lewy bodies [Disease or Syndrome]
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0242821:bodies [Human]
   804   C0332287:With [Qualitative Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1705690:With [Intellectual Product]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.66: It is a major source of distress to patients, exacerbates the carer's burden, and is a determinant of earlier transfer to institutional care and an increased mortality. 

Phrase: "It"

Phrase: "is"

Phrase: "a major source of distress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "to patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "exacerbates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0436331:exacerbate [Finding]

Phrase: "the carer's burden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828008:Burden [Idea or Concept]

Phrase: "and"

Phrase: "is"

Phrase: "a determinant of earlier transfer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521761:Determinant [Functional Concept]

Phrase: "to institutional care"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0868975:Institutional care [Health Care Activity]
   861   C1947933:Care [Activity]

Phrase: "and"

Phrase: "an increased mortality."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026565:Mortality [Quantitative Concept]
   861   C0026566:mortality [Quantitative Concept]
Processing 00000000.tx.67: Neuroleptic agents are usually the drugs of choice for psychosis in dementia. 

Phrase: "Neuroleptic agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040615:Neuroleptic Agents [Pharmacologic Substance]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "are"

Phrase: "usually"

Phrase: "the drugs of choice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0013227:Drugs [Pharmacologic Substance]
   737 E C1254351:Drug [Pharmacologic Substance]

Phrase: "for psychosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033975:Psychosis [Mental or Behavioral Dysfunction]
  1000   C0349204:Psychosis NOS [Mental or Behavioral Dysfunction]
   928 E C0459435:Psychotic [Finding]

Phrase: "in dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.68: In DLB, however, they are preferably avoided or used only with great caution, since severe neuroleptic sensitivity reactions can precipitate irreversible parkinsonism, further impair consciousness level, and induce autonomic disturbances reminiscent of neuroleptic malignant syndrome. 

Phrase: "In DLB,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   937   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0150312:In [Quantitative Concept]
   804   C0242821:bodies [Human]
   804   C0332285:In [Spatial Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "however,"

Phrase: "they"

Phrase: "are"

Phrase: "preferably"

Phrase: "avoided"

Phrase: "or"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "only with great caution,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205171:Only [Quantitative Concept]
   770   C0549177:Great [Quantitative Concept]
   770   C1704243:Great [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "since"

Phrase: "severe neuroleptic sensitivity reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   886   C3242604:severe reaction [Qualitative Concept]
   779   C0443286:Reaction [Functional Concept]
   779   C1114821:Reaction [Clinical Attribute]

Phrase: "can"

Phrase: "precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "irreversible parkinsonism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "impair"

Phrase: "consciousness level,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   964   C0456384:Conscious level [Qualitative Concept]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "autonomic disturbances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2699787:Disturbance [Qualitative Concept]

Phrase: "reminiscent of neuroleptic malignant syndrome."
Processing 00000000.tx.69: They occur in 40-50% of neuroleptic-treated patients with DLB and are associated with a two- to threefold increased mortality. 

Phrase: "They"

Phrase: "occur in 40-50% of neuroleptic-treated patients"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0040615:Neuroleptic [Pharmacologic Substance]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C0439509:/40 [Temporal Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1709305:Occur [Activity]
   744   C2745955:OCCUR [Temporal Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "with DLB"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   888   C0752347:dementia lewy bodies [Disease or Syndrome]
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0242821:bodies [Human]
   804   C0332287:With [Qualitative Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1705690:With [Intellectual Product]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "are"

Phrase: "associated with a two-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205448:Two [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to threefold"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "mortality."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]
Processing 00000000.tx.70: Acute D2 receptor blockade is thought to mediate these effects, and despite some promising initial reports, atypical and novel antipsychotic agents such as risperidone and olanzapine seem to be about as likely to cause adverse reactions as older, typical drugs. 

Phrase: "Acute D2 receptor blockade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332206:Blockade [Functional Concept]
   812   C3540676:Blockade [Pharmacologic Substance]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "these effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "and despite some"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "promising"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555307:promise [Idea or Concept]

Phrase: "initial reports,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "atypical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205182:Atypical [Qualitative Concept]
  1000   C0741302:Atypical [Finding]

Phrase: "and"

Phrase: "novel antipsychotic agents such as risperidone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0040615:Antipsychotic Agents [Pharmacologic Substance]
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C1254351:Agent [Pharmacologic Substance]
   719   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "olanzapine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171023:olanzapine [Organic Chemical,Pharmacologic Substance]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "about"

Phrase: "as"

Phrase: "likely to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]
   789 E C0033204:Likelihood [Quantitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "adverse reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0559546:Adverse reactions [Finding]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "as"

Phrase: "older, typical drugs."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C0013227:Drugs [Pharmacologic Substance]
   793 E C1254351:Drug [Pharmacologic Substance]
   755 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   755 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   727 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.71: Sedation, increased confusion and worsening of parkinsonism are the most common side-effects. 

Phrase: "Sedation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0235195:sedation [Finding]
  1000   C0344106:Sedation [Therapeutic or Preventive Procedure]

Phrase: "increased confusion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0009676:Confusion [Mental or Behavioral Dysfunction]
   861   C1963086:Confusion [Finding]
   789 E C1547301:Confused [Intellectual Product]

Phrase: "and"

Phrase: "worsening of parkinsonism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332271:Worsening [Qualitative Concept]
   790   C1457868:Worsening [Qualitative Concept]
   790   C1546960:Worsening [Idea or Concept]
   756 E C1279889:worsen [Finding]

Phrase: "are"

Phrase: "the most common side-effects."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0001688:side effects [Functional Concept]
   827 E C0879626:Side Effect [Pathologic Function]
   812   C0441987:Side [Spatial Concept]
   812   C1280500:effects [Qualitative Concept]
   779 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.72: Cholinesterase inhibitors There have been several reports that patients who respond well to cholinesterase inhibitor (ChEI) treatments are more likely to have DLB than Alzheimer's disease at autopsy. 

Phrase: "Cholinesterase inhibitors There"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0008425:Cholinesterase Inhibitors [Organic Chemical,Pharmacologic Substance]
   901   C2757012:Cholinesterase Inhibitors [Molecular Function]
   867 E C3536756:Cholinesterase Inhibitor [Pharmacologic Substance]
   827   C0008429:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "respond"

Phrase: "well to cholinesterase inhibitor (ChEI) treatments"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   806   C0008425:Cholinesterase Inhibitor [Organic Chemical,Pharmacologic Substance]
   806   C3536756:Cholinesterase Inhibitor [Pharmacologic Substance]
   760   C0008429:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0087111:Treatments [Therapeutic or Preventive Procedure]
   760   C0205170:Well [Qualitative Concept]
   760   C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1999216:Inhibitor [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]
   726 E C0039798:treatment [Functional Concept]
   726 E C1522326:Treatment [Functional Concept]
   726 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   726 E C1705169:Treatment [Conceptual Entity]
   726 E C3538994:TREATMENT [Research Activity]

Phrase: "are"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "DLB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "than Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "at autopsy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]
Processing 00000000.tx.73: This is consistent with the neurochemical profile of DLB and the fact that post-synaptic cortical muscarinic receptors are functionally intact. 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with the neurochemical profile of DLB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "the fact"

Phrase: "that post-synaptic cortical muscarinic receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0039064:Synaptic Receptors [Amino Acid, Peptide, or Protein,Receptor]
   840   C0034826:Receptors, Muscarinic [Amino Acid, Peptide, or Protein,Receptor]
   804   C0026815:muscarinic [Pharmacologic Substance]
   804   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "functionally intact."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205266:Intact [Qualitative Concept]
   861   C1554187:Intact [Idea or Concept]
Processing 00000000.tx.74: Case reports suggest that apathy, somnolence, hallucinations and delirium are symptoms of DLB that improve substantially with ChEI therapy (e.g. Samuel et al, 2000). 

Phrase: "Case reports"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007320:Case Reports [Intellectual Product]
   966 E C0085973:Case Report [Intellectual Product]
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that apathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085632:Apathy [Sign or Symptom]

Phrase: "somnolence,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013144:Somnolence [Finding]
  1000   C2830004:Somnolence [Finding]

Phrase: "hallucinations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018524:Hallucinations [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "delirium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011206:Delirium [Mental or Behavioral Dysfunction]

Phrase: "are"

Phrase: "symptoms of DLB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0683368:symptoms [Functional Concept]
   753   C1457887:Symptoms [Sign or Symptom]
   716   C0752347:Dementia with Lewy bodies [Disease or Syndrome]

Phrase: "that"

Phrase: "improve"

Phrase: "substantially with ChEI therapy"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0008425:Cholinesterase Inhibitor [Organic Chemical,Pharmacologic Substance]
   806   C3536756:Cholinesterase Inhibitor [Pharmacologic Substance]
   760   C0008429:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1363945:Therapy [Finding]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "("

Phrase: "e.g. Samuel et al,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.75: Eleven patients with DLB, mean age 78.5 years, treated with rivastigmine in an open-label study over 12 weeks had reductions in delusions (73%), apathy (61%), agitation (52%) and hallucinations (31%) compared with baseline. 

Phrase: "Eleven patients with DLB,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   831   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0205457:Eleven [Quantitative Concept]
   748   C0242821:bodies [Human]
   748   C0445482:Eleven [Organism Attribute]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "mean age 78.5 years,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C1510829:Age-Years [Temporal Concept]
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "treated with rivastigmine"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0649350:rivastigmine [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "in an open-label study"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1709323:Open Label Study [Research Activity]
           OPEN LABEL
   827   C0175566:Open [Spatial Concept]
   827   C0181496:Label [Manufactured Object]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
   827   C2827499:Label [Governmental or Regulatory Activity]
   755 E C0547049:Openness [Spatial Concept]

Phrase: "over 12 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "had"

Phrase: "reductions in delusions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0301630:reductions [Natural Phenomenon or Process]
   790   C0441610:reductions [Therapeutic or Preventive Procedure]
   756 E C0392756:Reduction [Qualitative Concept]

Phrase: "(73%"

Phrase: ")"

Phrase: ","

Phrase: "apathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085632:Apathy [Sign or Symptom]

Phrase: "(61%"

Phrase: ")"

Phrase: ","

Phrase: "agitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085631:Agitation [Sign or Symptom]

Phrase: "(52%"

Phrase: ")"

Phrase: "and"

Phrase: "hallucinations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018524:Hallucinations [Mental or Behavioral Dysfunction]

Phrase: "(31%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "compared with baseline."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0168634:baseline [Biomedical or Dental Material]
   790   C1442488:Baseline [Quantitative Concept]
   790   C1707455:Compared [Activity]
Processing 00000000.tx.76: Forty-five per cent (5) of the patients experienced significant clinical improvements, defined by a reduction of more than 50% in a composite score comprising hallucinations, delusions, apathy and agitation. 

Phrase: "Forty-five per cent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439165:Percent [Quantitative Concept]
   812   C0205451:Five [Quantitative Concept]
   812   C0562018:cent [Quantitative Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "of the patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "experienced"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0237607:experience [Mental Process]
   966   C0596545:Experience [Mental Process]

Phrase: "significant clinical improvements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2986411:Improvement [Conceptual Entity]

Phrase: "defined by a reduction of more"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]

Phrase: "than 50%"

Phrase: "in a composite score comprising hallucinations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018524:Hallucinations [Mental or Behavioral Dysfunction]

Phrase: "delusions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011253:Delusions [Mental or Behavioral Dysfunction]

Phrase: "apathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085632:Apathy [Sign or Symptom]

Phrase: "and"

Phrase: "agitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085631:Agitation [Sign or Symptom]
Processing 00000000.tx.77: Five of seven patients lost all of their delusions, three of eight stopped hallucinating and three had significantly fewer or less troublesome hallucinations. 

Phrase: "Five of seven patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205451:Five [Quantitative Concept]
   770   C0205453:Seven [Quantitative Concept]

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "all of their delusions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011253:Delusions [Mental or Behavioral Dysfunction]
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "three of eight stopped hallucinating"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0018524:hallucinating [Mental or Behavioral Dysfunction]
   760   C0205449:Three [Quantitative Concept]
   760   C0205454:Eight [Quantitative Concept]
   760   C1272691:stopped [Qualitative Concept]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]

Phrase: "and"

Phrase: "three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "had"

Phrase: "significantly fewer"

Phrase: "or"

Phrase: "less troublesome hallucinations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018524:Hallucinations [Mental or Behavioral Dysfunction]
Processing 00000000.tx.78: Carers and patients regarded these improvements, which had not previously been observed with other treatments, including low-dose neuroleptics, as substantial. 

Phrase: "Carers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085537:Carers [Professional or Occupational Group]
  1000   C1305660:carers [Professional or Occupational Group]

Phrase: "and"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "regarded"

Phrase: "these improvements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986411:Improvement [Conceptual Entity]

Phrase: "which"

Phrase: "had"

Phrase: "not previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "observed with other treatments,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   770   C1441672:Observed [Functional Concept]
   737 E C0039798:treatment [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "low-dose neuroleptics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040615:Neuroleptics [Pharmacologic Substance]
   734   C0445550:Low dose [Quantitative Concept]
   734   C1708745:Low-Dose [Research Activity]

Phrase: "as"

Phrase: "substantial."
Processing 00000000.tx.79: No patient became more Parkinsonian (McKeith et al, 2000a). 

Phrase: "No patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "became"

Phrase: "more Parkinsonian"

Phrase: "(McKeith et al,"

Phrase: "2000a"

Phrase: ")."
Processing 00000000.tx.80: A multi-centre, randomised controlled trial of rivastigmine supports these early case reports. 

Phrase: "A multi-centre,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205099:Center [Spatial Concept]
   861   C0439064:Multi [Quantitative Concept]

Phrase: "randomised controlled trial of rivastigmine"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   862   C0282440:randomized controlled trial [Intellectual Product,Research Activity]
   862   C1096777:Randomized Controlled Trial [Intellectual Product,Research Activity]
   760   C0008976:Trial [Research Activity]
   760   C2587213:Controlled [Functional Concept]
   726 E C0243148:control [Qualitative Concept]
   726 E C1550141:Control [Substance]
   726 E C1882979:Control [Conceptual Entity]
   726 E C3274648:Control [Qualitative Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "these early case reports."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007320:Case Reports [Intellectual Product]
   867 E C0085973:Case Report [Intellectual Product]
   827   C0684224:Reports [Intellectual Product]
   827   C0700287:reports [Health Care Activity]
   827   C0868928:Case [Functional Concept]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]
   793 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.81: One hundred and twenty patients from the UK, Spain and Italy, fulfilling consensus criteria for probable DLB, were given rivastigmine at daily doses up to 12 mg (mean end-dose 9.4 mg) or placebo for 20 weeks. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "hundred"

Phrase: "and"

Phrase: "twenty patients from the UK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "Spain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037747:Spain [Geographic Area]

Phrase: "and"

Phrase: "Italy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "fulfilling consensus criteria for probable DLB,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   818   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   767 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   764   C0085200:Lewy Bodies [Cell Component]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0033204:Probable [Quantitative Concept]
   742   C0242821:bodies [Human]
   742   C0243161:criteria [Intellectual Product]
   742   C0332148:Probable [Qualitative Concept]
   742   C0376298:Consensus [Social Behavior]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]
   742   C1995017:Bodies [Cell Component]
   708 E C0460148:Body [Anatomical Structure]
   708 E C1268086:Body [Anatomical Structure]
   708   C1550543:Fulfill [Idea or Concept]

Phrase: "were"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "rivastigmine at daily doses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0649350:rivastigmine [Organic Chemical,Pharmacologic Substance]

Phrase: "up to 12 mg (mean end-dose 9.4 mg)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   878   C1319635:mg/mg [Quantitative Concept]

Phrase: "or"

Phrase: "placebo for 20 weeks."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032042:placebo [Therapeutic or Preventive Procedure]
   770   C1696465:placebo [Biomedical or Dental Material]
   770   C1706408:PLACEBO [Research Activity]
Processing 00000000.tx.82: A 3-week drug-free period followed. 

Phrase: "A 3-week drug-free period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0439531:/period [Temporal Concept]
   804   C1948053:Period [Temporal Concept]
   733 E C0332182:Periodic [Temporal Concept]
   733 E C1706381:PERIODIC [Intellectual Product]
   704 E C0031084:Periodicities [Temporal Concept]

Phrase: "followed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.83: Patients on rivastigmine showed significantly reduced core psychiatric symptoms of DLB, i.e. they were less apathetic and had less anxiety, delusions and hallucinations while receiving treatment. 

Phrase: "Patients on rivastigmine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significantly reduced core psychiatric symptoms of DLB,"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   806   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   761 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   761   C3546702:Lewy body core [Cell Component]
   760   C0085200:Lewy Bodies [Cell Component]
   760   C0233401:Psychiatric symptoms [Sign or Symptom]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0205487:Psychiatric [Functional Concept]
   739   C0242821:bodies [Human]
   739   C0392756:Reduced [Qualitative Concept]
   739   C0444669:Core [Spatial Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C0683368:symptoms [Functional Concept]
   739   C1167518:core [Cell Component]
   739   C1457887:Symptoms [Sign or Symptom]
   739   C1706352:Core [Medical Device]
   739   C1882467:Core [Manufactured Object]
   739   C1995017:Bodies [Cell Component]
   739   C3274653:Core [Body Substance]
   706 E C0460148:Body [Anatomical Structure]
   706 E C1268086:Body [Anatomical Structure]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "they"

Phrase: "were"

Phrase: "less apathetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085632:Apathetic [Sign or Symptom]

Phrase: "and"

Phrase: "had"

Phrase: "less anxiety,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003467:Anxiety [Mental Process]
   861   C0003469:Anxiety [Mental or Behavioral Dysfunction]

Phrase: "delusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011253:Delusions [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "hallucinations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018524:Hallucinations [Mental or Behavioral Dysfunction]

Phrase: "while"

Phrase: "receiving treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.84: Approximately twice as many patients on rivastigmine (63%) as on placebo (30%) showed at least a 30% improvement from baseline with regard to psychiatric symptoms typical of DLB. 

Phrase: "Approximately twice as many patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0332232:Approximately [Qualitative Concept]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "on rivastigmine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0649350:rivastigmine [Organic Chemical,Pharmacologic Substance]

Phrase: "(63%"

Phrase: ")"

Phrase: "as on placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032042:placebo [Therapeutic or Preventive Procedure]
   827   C1696465:placebo [Biomedical or Dental Material]
   827   C1706408:PLACEBO [Research Activity]

Phrase: "(30%"

Phrase: ")"

Phrase: "showed at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "a 30% improvement from baseline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986411:Improvement [Conceptual Entity]

Phrase: "with regard to psychiatric symptoms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0233401:Psychiatric symptoms [Sign or Symptom]
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]

Phrase: "typical of DLB."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C3538928:Typical [Qualitative Concept]
   716   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
Processing 00000000.tx.85: Active-treatment patients were also able to perform significantly faster and better on a computerised battery of neuropsychological tests, particularly on tasks with a substantial attentional component. 

Phrase: "Active-treatment patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C1704532:Active Treatment [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "also able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "significantly faster"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015663:Fast [Finding]
   827   C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "better on a computerised battery of neuropsychological tests,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332272:Better [Qualitative Concept]

Phrase: "particularly on tasks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C3540678:Task [Occupational Activity]

Phrase: "with a substantial attentional component."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.86: After drug discontinuation the differences between rivastigmine and placebo tended to disappear. 

Phrase: "After drug discontinuation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0457454:Discontinuation [Health Care Activity]
   861   C1444662:Discontinuation [Finding]

Phrase: "the differences between rivastigmine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disappear."
Processing 00000000.tx.87: Some of the known adverse events of ChEI (nausea, vomiting, anorexia) were seen more frequently on rivastigmine than on placebo, but safety and tolerability of the drug were judged acceptable (McKeith et al, 2000b). 

Phrase: "Some of the known adverse events of ChEI"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0008425:Cholinesterase Inhibitor [Organic Chemical,Pharmacologic Substance]
   764   C0877248:adverse events [Finding]
   764   C1705413:Adverse Events [Idea or Concept]
   764   C3536756:Cholinesterase Inhibitor [Pharmacologic Substance]
   742   C0008429:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205309:Known [Qualitative Concept]
   742   C0205392:Some [Quantitative Concept]
   742   C0441471:Events [Event]
   742   C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1999216:Inhibitor [Qualitative Concept]
   742   C3540770:Some [Intellectual Product]
   742   C3541888:Events [Classification]

Phrase: "(nausea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027497:Nausea [Sign or Symptom]
  1000   C1963179:Nausea [Finding]

Phrase: "vomiting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042963:Vomiting [Sign or Symptom]
  1000   C1963281:Vomiting [Finding]
   966 E C0042965:Vomit [Body Substance]

Phrase: ","

Phrase: "anorexia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003123:Anorexia [Disease or Syndrome]

Phrase: ")"

Phrase: "were"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "more frequently on rivastigmine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205172:More [Functional Concept]
   770   C0332183:Frequently [Temporal Concept]
   770   C0649350:rivastigmine [Organic Chemical,Pharmacologic Substance]

Phrase: "than"

Phrase: "on placebo,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "but"

Phrase: "safety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036043:Safety [Human-caused Phenomenon or Process]
  1000   C1705187:SAFETY [Research Activity]

Phrase: "and"

Phrase: "tolerability of the drug"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3274448:TOLERABILITY [Research Activity]

Phrase: "were"

Phrase: "judged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0221191:Judge [Professional or Occupational Group]

Phrase: "acceptable"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1879533:Acceptable [Qualitative Concept]
  1000   C3539083:Acceptable [Qualitative Concept]
   928 E C0814633:acceptability [Qualitative Concept]
   928 E C3645535:Acceptability [Qualitative Concept]

Phrase: "(McKeith et al,"

Phrase: "2000b"

Phrase: ")."
Processing 00000000.tx.88: Although further, confirmatory studies are required, there is substantial evidence accumulating that ChEIs are effective in some (although not all) DLB patients, and the class should be considered as first-line pharmacological treatments for cognitive dysfunction, apathy, psychosis and agitation in this disorder. 

Phrase: "Although"

Phrase: "further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmatory studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: ","

Phrase: "there"

Phrase: "is"

Phrase: "substantial evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "accumulating"

Phrase: "that ChEIs"

Phrase: "are"

Phrase: "effective in some"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280519:effective [Qualitative Concept]
   790   C1704419:Effective [Qualitative Concept]

Phrase: "("

Phrase: "although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all) DLB patients,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "the class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "considered as first-line pharmacological treatments"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   809   C1708063:First-Line Treatment [Therapeutic or Preventive Procedure]
   790   C0013216:Pharmacological Treatments [Therapeutic or Preventive Procedure]
   753   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   753   C0087111:Treatments [Therapeutic or Preventive Procedure]
   753   C0205132:Line [Spatial Concept]
   753   C0205435:First [Quantitative Concept]
   753   C0205464:pharmacological [Functional Concept]
   753   C0750591:considered [Idea or Concept]
   753   C1279901:First [Qualitative Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   719 E C0039798:treatment [Functional Concept]
   719 E C1522326:Treatment [Functional Concept]
   719 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   719 E C1705169:Treatment [Conceptual Entity]
   719 E C3538994:TREATMENT [Research Activity]

Phrase: "for cognitive dysfunction,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "apathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085632:Apathy [Sign or Symptom]

Phrase: "psychosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033975:Psychosis [Mental or Behavioral Dysfunction]
  1000   C0349204:Psychosis NOS [Mental or Behavioral Dysfunction]
   928 E C0459435:Psychotic [Finding]

Phrase: "and"

Phrase: "agitation in this disorder."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085631:Agitation [Sign or Symptom]
Processing 00000000.tx.89: Other medications There is no available information about the effects of antidepressants, anticonvulsants or benzodiazepines on psychiatric and behavioural symptoms. 

Phrase: "Other medications There"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0013227:Medications [Pharmacologic Substance]
   861   C0802604:Medications [Clinical Attribute]
   861   C2598133:Medications [Clinical Attribute]
   827 E C3244316:medication [Functional Concept]

Phrase: "is"

Phrase: "no available information about the effects of antidepressants,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   789   C1546437:No Information Available [Qualitative Concept]
           No Information
   767   C1549058:No Information [Idea or Concept]
   744   C1533716:Information [Idea or Concept]

Phrase: "anticonvulsants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003286:Anticonvulsants [Pharmacologic Substance]

Phrase: "or"

Phrase: "benzodiazepines on psychiatric"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0005064:Benzodiazepines [Organic Chemical,Pharmacologic Substance]
   756 E C3536850:Benzodiazepine [Pharmacologic Substance]

Phrase: "and"

Phrase: "behavioural symptoms."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004941:Behavioral Symptoms [Sign or Symptom]
  1000   C2707011:Behavioral symptoms [Clinical Attribute]
   861   C0683368:symptoms [Functional Concept]
   861   C1457887:Symptoms [Sign or Symptom]
Processing 00000000.tx.90: It has been suggested that clonazepam may be helpful in controlling the characteristic sleep disturbance of DLB with its vivid dreams and a loss of normal muscle atonia in rapid eye movement sleep, which lead to excessive jerking or complex vigorous movements. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that clonazepam"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009011:Clonazepam [Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "helpful in controlling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   718   C0018896:Help [Social Behavior]
   718   C1552861:help [Idea or Concept]

Phrase: "the characteristic sleep disturbance of DLB"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   818   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   767 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   764   C0037317:Sleep disturbance [Sign or Symptom]
   764   C0085200:Lewy Bodies [Cell Component]
   764   C0700201:Sleep disturbance [Disease or Syndrome]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0037313:Sleep [Organism Function]
   742   C0242821:bodies [Human]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]
   742   C1521970:Characteristic [Qualitative Concept]
   742   C1995017:Bodies [Cell Component]
   742   C2699787:Disturbance [Qualitative Concept]
   708 E C0460148:Body [Anatomical Structure]
   708 E C1268086:Body [Anatomical Structure]

Phrase: "with its vivid dreams"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0344320:VIVID DREAMS [Finding]
   861   C0013117:Dreams [Mental Process]
   827 E C1825644:DREAM [Gene or Genome]

Phrase: "and"

Phrase: "a loss of normal muscle atonia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "in rapid eye movement sleep,"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
  1000   C0037322:Rapid eye movement sleep [Mental Process]
   923   C0034673:rapid eye movement [Organ or Tissue Function]
   861   C0015413:Eye movement, NOS [Organ or Tissue Function]
   861   C0702182:eye movement [Finding]
   812   C0015392:Eye [Body Part, Organ, or Organ Component]
   812   C0026649:Movement [Organism Function]
   812   C0037313:Sleep [Organism Function]
   812   C0439831:Rapid [Qualitative Concept]
   812   C1280202:Eye [Body Part, Organ, or Organ Component]
   756 E C0029144:optic [Occupation or Discipline]
   756 E C0042789:Ocular [Organism Function]
   756 E C1299003:Ocular [Spatial Concept]
   741 E C0013144:Sleepy [Finding]
   719 E C0014236:Ophthalmia [Disease or Syndrome]
   719 E C0700042:Oculus [Body Location or Region]
   712 E C2830004:SLEEPINESS [Finding]

Phrase: "which"

Phrase: "lead to excessive jerking"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0231530:jerking [Sign or Symptom]
   770   C0442802:Excessive [Qualitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1704276:Jerking [Sign or Symptom]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "complex vigorous movements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026649:Movement [Organism Function]
Processing 00000000.tx.91: Although limited levodopa responsiveness has generally been reported in DLB, this may reflect a failure to treat, or underdosage, because of concerns about exacerbating psychotic symptoms. 

Phrase: "Although"

Phrase: "limited levodopa responsiveness"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   755   C0205342:Responsive [Functional Concept]
   727 E C2371924:Responsivity [Mental Process]

Phrase: "has"

Phrase: "generally"

Phrase: "been"

Phrase: "reported in DLB,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   790   C0085200:Lewy Bodies [Cell Component]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0242821:bodies [Human]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1995017:Bodies [Cell Component]
   753   C3496591:Reported [Clinical Attribute]
   719 E C0460148:Body [Anatomical Structure]
   719 E C1268086:Body [Anatomical Structure]
   719 E C3273238:Report [Intellectual Product]

Phrase: "this"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: ","

Phrase: "or"

Phrase: "underdosage,"

Phrase: "because of concerns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699424:Concerns [Idea or Concept]

Phrase: "about exacerbating psychotic symptoms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0871189:psychotic symptoms [Sign or Symptom]
   827   C0683368:symptoms [Functional Concept]
   827   C1457887:Symptoms [Sign or Symptom]
Processing 00000000.tx.92: A cautious trial of levodopa is recommended in DLB patients with clinically significant motor disability. 

Phrase: "A cautious trial of levodopa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0008976:Trial [Research Activity]

Phrase: "is"

Phrase: "recommended in DLB patients"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0034866:Recommended [Idea or Concept]
   748   C0242821:bodies [Human]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "with clinically significant motor disability."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0231170:Disability [Finding]
   741 E C0018576:Disabled [Patient or Disabled Group]
   741 E C1880351:Disabled [Qualitative Concept]
Processing 00000000.tx.93: Clinical Implications and Limitations CLINICAL IMPLICATIONS Dementia with Lewy bodies (DLB) accounts for 15-20% of all dementia in old age that can now be accurately diagnosed using operationalised criteria. 

Phrase: "Clinical Implications"

Phrase: "and"

Phrase: "Limitations CLINICAL IMPLICATIONS Dementia with Lewy bodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(DLB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "accounts for 15-20% of all dementia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1631070:20/15 [Finding]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1551359:account [Idea or Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]

Phrase: "in old age"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0231337:Old age [Finding]
  1000   C1999167:Old age [Population Group]
   944 E C0392079:Senile [Finding]
   861   C0001779:Age [Organism Attribute]
   861   C0580836:Old [Temporal Concept]

Phrase: "that"

Phrase: "can"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "be"

Phrase: "accurately"

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "operationalised criteria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.94: The most frequent clinical misdiagnosis of DLB is as Alzheimer's disease. 

Phrase: "The most frequent clinical misdiagnosis of DLB"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   761 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0085200:Lewy Bodies [Cell Component]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0205210:Clinical [Qualitative Concept]
   739   C0242821:bodies [Human]
   739   C0332183:Frequent [Temporal Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C0679838:Misdiagnosis [Finding]
   739   C1995017:Bodies [Cell Component]
   706 E C0460148:Body [Anatomical Structure]
   706 E C1268086:Body [Anatomical Structure]

Phrase: "is as Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.95: Fifty per cent of patients with DLB show neuroleptic sensitivity reactions with a two- to threefold increase in mortality. 

Phrase: "Fifty per cent of patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0439165:Percent [Quantitative Concept]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0562018:cent [Quantitative Concept]

Phrase: "with DLB"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   888   C0752347:dementia lewy bodies [Disease or Syndrome]
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0242821:bodies [Human]
   804   C0332287:With [Qualitative Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1705690:With [Intellectual Product]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "neuroleptic sensitivity reactions with a two-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0443286:Reaction [Functional Concept]
   719   C1114821:Reaction [Clinical Attribute]

Phrase: "to threefold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in mortality."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]
Processing 00000000.tx.96: Cholinesterase inhibitors improve cognition, psychosis and other neuropsychiatric features in DLB. 

Phrase: "Cholinesterase inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0008425:Cholinesterase Inhibitors [Organic Chemical,Pharmacologic Substance]
  1000   C2757012:Cholinesterase Inhibitors [Molecular Function]
   966 E C3536756:Cholinesterase Inhibitor [Pharmacologic Substance]
   861   C0008429:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033791:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "improve"

Phrase: "cognition,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "psychosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033975:Psychosis [Mental or Behavioral Dysfunction]
  1000   C0349204:Psychosis NOS [Mental or Behavioral Dysfunction]
   928 E C0459435:Psychotic [Finding]

Phrase: "and"

Phrase: "other neuropsychiatric features in DLB."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   833   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   776 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0085200:Lewy Bodies [Cell Component]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0205394:Other [Qualitative Concept]
   744   C0242821:bodies [Human]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]
   744   C1995017:Bodies [Cell Component]
   711 E C0460148:Body [Anatomical Structure]
   711 E C1268086:Body [Anatomical Structure]
   711   C1521970:Feature [Qualitative Concept]
   711   C1706388:Feature [Conceptual Entity]
   711   C2346469:Feature [Qualitative Concept]
   711   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.97: They may soon become established as first-line treatment. 

Phrase: "They"

Phrase: "may"

Phrase: "soon"

Phrase: "become"

Phrase: "established as first-line treatment."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   862   C1708063:First-Line Treatment [Therapeutic or Preventive Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0205132:Line [Spatial Concept]
   760   C0205435:First [Quantitative Concept]
   760   C0443211:Established [Qualitative Concept]
   760   C1272684:Established [Qualitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.98: LIMITATIONS Diagnostic accuracy for DLB has not yet been established outside specialised research settings. 

Phrase: "LIMITATIONS Diagnostic accuracy for DLB"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   833   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   776 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0085200:Lewy Bodies [Cell Component]
   770   C0598285:Diagnostic Accuracy [Qualitative Concept]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0011900:Diagnostic [Finding]
   744   C0242821:bodies [Human]
   744   C0348026:Diagnostic [Functional Concept]
   744   C0443131:Accuracy [Qualitative Concept]
   744   C0449295:limitations [Functional Concept]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]
   744   C1995017:Bodies [Cell Component]
   711 E C0460148:Body [Anatomical Structure]
   711 E C1268086:Body [Anatomical Structure]

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "outside specialised research settings."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   779   C0542559:setting [Functional Concept]
   779   C1318139:{Setting} [Quantitative Concept]
Processing 00000000.tx.99: The boundaries between DLB and Parkinson's disease with dementia/psychosis remain indistinct. 

Phrase: "The boundaries between DLB"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0242821:bodies [Human]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "Parkinson's disease with dementia/psychosis"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   844   C0349081:dementia parkinson's disease [Disease or Syndrome]
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "remain"

Phrase: "indistinct."
Processing 00000000.tx.100: The National Institute for Clinical Excellence does not yet recommend the use of cholinesterase inhibitors in DLB. 

Phrase: "The National Institute for Clinical Excellence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: "does"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "recommend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034866:recommend [Idea or Concept]

Phrase: "the use of cholinesterase inhibitors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "in DLB."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   937   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0150312:In [Quantitative Concept]
   804   C0242821:bodies [Human]
   804   C0332285:In [Spatial Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.101: Further placebo-controlled trials are urgently needed. 

Phrase: "Further placebo-controlled trials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0008976:Trial [Research Activity]

Phrase: "are"

Phrase: "urgently"

Phrase: "needed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]
Processing 00000000.tx.102: APPENDIX Consensus criteria for the clinical diagnosis of probable and possible dementia with Lewy bodies The central feature required for a diagnosis of dementia with Lewy bodies (DLB) is progressive cognitive decline of sufficient magnitude to interfere with normal social or occupational function. 

Phrase: "APPENDIX Consensus criteria for the clinical diagnosis of probable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "possible dementia with Lewy bodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   926   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   827 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "The central feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]

Phrase: "required for a diagnosis of dementia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0011900:Diagnosis [Finding]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C1514873:Required [Functional Concept]
   753   C1704338:diagnosis [Qualitative Concept]
   753   C1704656:DIAGNOSIS [Research Activity]

Phrase: "with Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(DLB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "is"

Phrase: "progressive cognitive decline of sufficient magnitude to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C1863063:Cognitive decline, progressive [Finding]
   778   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "interfere with normal social"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0521102:Interfere [Qualitative Concept]
   770   C0728831:Social [Functional Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "occupational function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.103: Prominent or persistent memory impairment may not necessarily occur in the early stages but is usually evident with progression. 

Phrase: "Prominent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205402:Prominent [Qualitative Concept]

Phrase: "or"

Phrase: "persistent memory impairment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0233794:Memory impairment [Mental or Behavioral Dysfunction]
   901   C1963167:Memory impairment [Finding]
   827   C0684336:Impairment [Pathologic Function]
   734   C1882350:Persistent Memory [Manufactured Object]

Phrase: "may"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "occur in the early stages"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C2363430:early stages [Temporal Concept]
   790 E C1517886:Early Stage [Classification]
   760   C1279919:Early [Temporal Concept]
   760   C1306673:Stages [Qualitative Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726 E C0205390:Stage [Temporal Concept]
   726 E C1300072:Stage [Clinical Attribute]

Phrase: "but"

Phrase: "is"

Phrase: "usually evident with progression."
Processing 00000000.tx.104: Deficits on tests of attention and of frontal-subcortical skills and visuospatial ability may be especially prominent. 

Phrase: "Deficits on tests of attention"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0041671:Attention deficits [Mental or Behavioral Dysfunction]
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "and of frontal-subcortical skills"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205123:Frontal [Spatial Concept]
   760   C0678856:skills [Individual Behavior]
   760   C0815275:subcortical [Body Location or Region]
   760   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "visuospatial ability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0814069:visuospatial ability [Mental Process]
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "especially prominent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205402:Prominent [Qualitative Concept]
Processing 00000000.tx.105: Two of the following core features are essential for a diagnosis of probable DLB, one is essential for possible DLB. 

Phrase: "Two of the following core features"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205448:Two [Quantitative Concept]

Phrase: "are"

Phrase: "essential for a diagnosis of probable DLB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205224:Essential [Qualitative Concept]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "essential for possible DLB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.106: Fluctuating cognition with pronounced variations in attention and alertness. 

Phrase: "Fluctuating cognition with pronounced variations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009240:Cognition [Mental Process]

Phrase: "in attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004268:Attention [Mental Process]

Phrase: "and"

Phrase: "alertness."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1443086:Alertness [Mental Process]
   928 E C0239110:ALERT [Finding]
Processing 00000000.tx.107: Recurrent visual hallucinations which are typically well formed and detailed. 

Phrase: "Recurrent visual hallucinations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0233763:Hallucinations, Visual [Sign or Symptom]
   827   C0018524:Hallucinations [Mental or Behavioral Dysfunction]
   827   C0234621:Visual [Functional Concept]

Phrase: "which"

Phrase: "are"

Phrase: "typically well formed"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C0205431:Formed [Functional Concept]
   827   C3146287:Well [Manufactured Object]
   793 E C0348078:Form [Qualitative Concept]
   793 E C0376315:Form [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "detailed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]
Processing 00000000.tx.108: Spontaneous motor features of parkinsonism. 

Phrase: "Spontaneous motor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1513492:Motor [Functional Concept]
   861   C1705994:Motor [Manufactured Object]

Phrase: "features of parkinsonism."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0242422:Parkinsonism [Disease or Syndrome]
   790   C1521970:Feature [Qualitative Concept]
   790   C1706388:Feature [Conceptual Entity]
   790   C2346469:Feature [Qualitative Concept]
   790   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.109: Features supportive of the diagnosis are: Repeated falls Syncope Transient loss of consciousness Neuroleptic sensitivity Systematised delusions Hallucinations in other modalities. 

Phrase: "Features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "supportive of the diagnosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521721:Supportive [Conceptual Entity]

Phrase: "are"

Phrase: ":"

Phrase: "Repeated falls Syncope Transient loss of consciousness Neuroleptic sensitivity Systematised delusions Hallucinations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041657:Loss of consciousness [Finding]
   736   C1517945:Loss [Quantitative Concept]

Phrase: "in other modalities."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0695347:modalities [Idea or Concept]
   966 E C1547664:Modality [Diagnostic Procedure]
Processing 00000000.tx.110: A diagnosis of DLB is less likely in the presence of: Stroke disease, evident as focal neurological signs or on brain imaging. 

Phrase: "A diagnosis of DLB"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0011900:Diagnosis [Finding]
   748   C0242821:bodies [Human]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1704338:diagnosis [Qualitative Concept]
   748   C1704656:DIAGNOSIS [Research Activity]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "is"

Phrase: "less likely in the presence of"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0332148:Likely [Qualitative Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0439092:less [Intellectual Product]
   753   C0547044:Less [Qualitative Concept]
   753   C0750492:Likely [Idea or Concept]

Phrase: ":"

Phrase: "Stroke disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "evident as focal neurological signs"

Phrase: "or on brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "imaging."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.111: Evidence on physical examination and investigation of any physical illness, or other brain disorder, sufficient to account for the clinical picture. 

Phrase: "Evidence on physical examination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "investigation of any physical illness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Investigation [Health Care Activity]
   760   C1552578:investigation [Idea or Concept]

Phrase: "or"

Phrase: "other brain disorder,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006111:Brain Disorder [Disease or Syndrome]
   861   C0012634:Disorder [Disease or Syndrome]

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "account for the clinical picture."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205210:Clinical [Qualitative Concept]
   760   C0441468:picture [Manufactured Object]
   760   C0441469:Picture [Manufactured Object]
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]
Processing 00000000.tx.112: See McKeith et al (1996). 

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "McKeith et al (1996"

Phrase: ")."
Processing 00000000.tx.113: REFERENCES Barber, R., Scheltens, P., Gholkar, A., et al (1999) White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Barber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335371:Barber [Professional or Occupational Group]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Scheltens,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gholkar,"

Phrase: "A.,"

Phrase: "et al (1999"

Phrase: ")"

Phrase: "White matter lesions on magnetic resonance imaging"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   814   C2752009:White matter lesions [Finding]
   778   C0682708:White matter [Tissue]
   748   C0007457:White [Population Group]
   748   C0043157:White [Population Group]
   748   C0220938:White [Qualitative Concept]
   748   C0221198:lesions [Finding]
   714 E C1546698:Lesion [Intellectual Product]

Phrase: "in dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "with Lewy bodies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "vascular dementia,"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "normal aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]
Processing 00000000.tx.114: Journal of Neurology, Neurosurgery and Psychiatry, 67, 66-72.[Abstract/Free FullText] Byrne, E. 

Phrase: "Journal of Neurology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "Neurosurgery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027926:Neurosurgery [Biomedical Occupation or Discipline]
  1000   C0524850:Neurosurgery [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "67,"

Phrase: "66-72."

Phrase: "[Abstract/Free FullText"

Phrase: "] Byrne,"

Phrase: "E."
Processing 00000000.tx.115: J., Lennox, G., Lowe, J., et al (1989) Diffuse Lewy body disease: clinical features in 15 cases. 

Phrase: "J.,"

Phrase: "Lennox,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lowe,"

Phrase: "J.,"

Phrase: "et al (1989"

Phrase: ")"

Phrase: "Diffuse Lewy body disease"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0752347:Diffuse Lewy Body Disease [Disease or Syndrome]
           Lewy Body Disease
   861   C0085200:Lewy Body [Cell Component]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0205219:Diffuse [Qualitative Concept]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   729 E C1995017:Bodies [Cell Component]

Phrase: ":"

Phrase: "clinical features in 15 cases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.116: Journal of Neurology, Neurosurgery and Psychiatry, 52, 709-717.[Abstract] Gmez-Tortosa, E., Newell, K., Irizarry, M. 

Phrase: "Journal of Neurology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "Neurosurgery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027926:Neurosurgery [Biomedical Occupation or Discipline]
  1000   C0524850:Neurosurgery [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "52,"

Phrase: "709-717."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gmez-Tortosa,"

Phrase: "E.,"

Phrase: "Newell,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.117: C., et al (1999) Clinical and quantitative pathologic correlates of dementia with Lewy bodies. 

Phrase: "C., et al (1999"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "quantitative pathologic correlates of dementia"

Phrase: "with Lewy bodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.118: Neurology, 53, 1284-1291.[Abstract/Free FullText] Holmes, C., Cairns, N., Lantos, P., et al (1999) Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "53,"

Phrase: "1284-1291."

Phrase: "[Abstract/Free FullText"

Phrase: "] Holmes,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Cairns,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lantos,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "et al (1999"

Phrase: ")"

Phrase: "Validity of current clinical criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C2699472:Criterion Validity [Quantitative Concept]
   760   C2349101:Validity [Quantitative Concept]

Phrase: "for Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "vascular dementia"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "dementia with Lewy bodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.119: British Journal of Psychiatry, 174, 45-50.[Abstract] McKeith, I. 

Phrase: "British Journal of Psychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "174,"

Phrase: "45-50."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McKeith,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.120: G., Perry, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Perry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.121: H., Fairbairn, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fairbairn,"

Phrase: "A."
Processing 00000000.tx.122: F., et al (1992) Operational criteria for senile dementia of Lewy body type (SDLT). 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "et al (1992"

Phrase: ")"

Phrase: "Operational criteria for senile dementia of Lewy body type (SDLT)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.123: Psychological Medicine, 22, 911-922.[Medline] McKeith, I. 

Phrase: "Psychological Medicine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C0175852:psychology medicine [Biomedical Occupation or Discipline]
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "22,"

Phrase: "911-922."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McKeith,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.124: G., Galasko, D., Kosaka, K., et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Galasko,"

Phrase: "D."

Phrase: ","

Phrase: "Kosaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "et al (1996"

Phrase: ")"

Phrase: "Consensus guidelines for the clinical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0162791:Guidelines [Intellectual Product]
   760   C0220845:guidelines [Intellectual Product]
   760   C0282423:guidelines [Intellectual Product]

Phrase: "and"

Phrase: "pathologic diagnosis of dementia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0332142:Pathology diagnosis [Functional Concept]
   770   C0011900:Diagnosis [Finding]
   770   C1521733:Pathologic [Functional Concept]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]

Phrase: "with Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(DLB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: ":"

Phrase: "report of the consortium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C3273238:Report [Intellectual Product]

Phrase: "on DLB international workshop."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   877   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   818   C0085200:Lewy Bodies [Cell Component]
   795   C0011265:dementia [Mental or Behavioral Dysfunction]
   795   C0242262:Workshop [Educational Activity]
   795   C0242821:bodies [Human]
   795   C0497327:Dementia [Mental or Behavioral Dysfunction]
   795   C0677507:Workshop [Manufactured Object]
   795   C1512888:International [Idea or Concept]
   795   C1720176:On [Functional Concept]
   795   C1720294:On [Intellectual Product]
   795   C1995017:Bodies [Cell Component]
   762 E C0460148:Body [Anatomical Structure]
   762 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.125: Neurology, 47, 1113-1124.[Abstract] McKeith, I. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "47,"

Phrase: "1113-1124."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McKeith,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.126: G., Grace, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Grace,"

Phrase: "J."
Processing 00000000.tx.127: B., Walker, Z., et al (2000a) Rivastigmine in the treatment of dementia with Lewy bodies. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "Z.,"

Phrase: "et al (2000a"

Phrase: ")"

Phrase: "Rivastigmine in the treatment of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0649350:rivastigmine [Organic Chemical,Pharmacologic Substance]

Phrase: "with Lewy bodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.128: Preliminary findings from an open trial. 

Phrase: "Preliminary findings from an open trial."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]
Processing 00000000.tx.129: International Journal of Geriatric Psychiatry, 15, 387-392.[CrossRef][Medline] McKeith, I. 

Phrase: "International Journal of Geriatric Psychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "15,"

Phrase: "387-392."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McKeith,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.130: G., Spano, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Spano,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.131: F., Del Ser, T., et al (2000b) Efficacy of rivastigmine in dementia with Lewy bodies: results of a randomised placebo-controlled international study. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Del Ser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "et al (2000b"

Phrase: ")"

Phrase: "Efficacy of rivastigmine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280519:Efficacy [Qualitative Concept]
   790   C1707887:EFFICACY [Research Activity]

Phrase: "in dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "with Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: ":"

Phrase: "results of a randomised placebo-controlled international study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0683954:results study [Finding]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]
Processing 00000000.tx.132: Lancet, 356, 2031-2036.[CrossRef][Medline] Samuel, W., Caliguri, M., Galasko, D., et al (2000) Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "356,"

Phrase: "2031-2036."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Samuel,"

Phrase: "W.,"

Phrase: "Caliguri,"

Phrase: "M."

Phrase: ","

Phrase: "Galasko,"

Phrase: "D."

Phrase: ","

Phrase: "et al (2000"

Phrase: ")"

Phrase: "Better cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516691:Cognitive [Functional Concept]

Phrase: "and"

Phrase: "psychopathologic response to donepezil"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "in patients prospectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "diagnosed as dementia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0011900:Diagnosed [Finding]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "with Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: ":"

Phrase: "a preliminary study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439611:Preliminary [Temporal Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.133: International Journal of Geriatric Psychiatry, 15, 794-802.[CrossRef][Medline] Walker, M. 

Phrase: "International Journal of Geriatric Psychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "15,"

Phrase: "794-802."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.134: P., Ballard, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ballard,"

Phrase: "C."
Processing 00000000.tx.135: G., Ayre, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ayre,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.136: A., et al (2000) The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. 

Phrase: "A.,"

Phrase: "et al (2000"

Phrase: ")"

Phrase: "The Clinician Assessment of Fluctuation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "and"

Phrase: "the One Day Fluctuation Assessment Scale."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C0450973:assessment scale [Intellectual Product]
   804   C0175659:Scale [Medical Device]
   804   C0349674:Scale [Intellectual Product]
   804   C1947916:Scale [Activity]
   804   C3536777:Scale [Manufactured Object]
   733 E C1710017:Scalar [Qualitative Concept]
   721 E C0222045:Scales [Body Part, Organ, or Organ Component]
Processing 00000000.tx.137: Two methods to assess fluctuating confusion in dementia. 

Phrase: "Two methods to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "fluctuating confusion in dementia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0009676:Confusion [Mental or Behavioral Dysfunction]
   770   C1963086:Confusion [Finding]
Processing 00000000.tx.138: British Journal of Psychiatry, 177, 252-256.[Abstract/Free FullText] Walker, Z., Costa, D. 

Phrase: "British Journal of Psychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "177,"

Phrase: "252-256."

Phrase: "[Abstract/Free FullText"

Phrase: "] Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "Z.,"

Phrase: "Costa,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035561:Costa [Body Part, Organ, or Organ Component]
   907 E C1281577:Rib [Body Part, Organ, or Organ Component]

Phrase: "D."
Processing 00000000.tx.139: C., Inca, P., et al (1999) In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. 

Phrase: "C., Inca,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337871:Inca [Population Group]
   861   C1836112:INCA [Gene or Genome]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "et al (1999"

Phrase: ")"

Phrase: "In-vivo demonstration of dopaminergic degeneration"

Phrase: "in dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "with Lewy bodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.140: Lancet, 354, 646-647.[CrossRef][Medline] Weiner, M. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "354,"

Phrase: "646-647."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weiner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.141: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.142: (1999) Dementia associated with Lewy bodies. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "associated with Lewy bodies."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0085200:Lewy Bodies [Cell Component]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1268086:Body [Anatomical Structure]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.143: Archives of Neurology, 56, 1441-1442.[Free FullText] Received for publication March 20, 2000. 

Phrase: "Archives of Neurology,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0003738:Archives [Manufactured Object]
   790   C0027855:Neurology [Biomedical Occupation or Discipline]
   790   C1554162:Archive [Idea or Concept]
   718 E C0205494:Neurologic [Qualitative Concept]
   718 E C2707261:Neurological [Clinical Attribute]

Phrase: "56,"

Phrase: "1441-1442."

Phrase: "[Free FullText"

Phrase: "]"

Phrase: "Received for publication March 20,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2000."
Processing 00000000.tx.144: Revision received August 8, 2001. 

Phrase: "Revision"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439617:Revision [Temporal Concept]
  1000   C0558347:Revision [Therapeutic or Preventive Procedure]
  1000   C1527075:Revision [Therapeutic or Preventive Procedure]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "August 8,"

Phrase: "2001."
Processing 00000000.tx.145: Accepted for publication August 8, 2001. 

Phrase: "Accepted for publication August 8,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.146: Related articles in BJP: Highlights of this issue ELIZABETH WALSH BJP 2002 180: 0. 

Phrase: "Related articles in BJP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1706852:Article [Intellectual Product]

Phrase: ":"

Phrase: "Highlights of this issue ELIZABETH WALSH BJP 2002 180"

Phrase: ":"

Phrase: "0."
Processing 00000000.tx.147: [Full Text]  Old age psychiatry ALISTAIR BURNS and IAN G. 

Phrase: "[Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1527021:Text [Intellectual Product]
   861   C1554111:Text [Idea or Concept]
   861   C1705606:Text [Intellectual Product]
   861   C3541382:Text [Intellectual Product]

Phrase: "]  Old age psychiatry ALISTAIR BURNS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0006434:Burns [Injury or Poisoning]
   771 E C1550619:Burn [Substance]
   717   C1273857:Old age psychiatry [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "IAN G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.148: McKEITH BJP 2002 180: 97-98. 

Phrase: "McKEITH BJP 2002 180"

Phrase: ":"

Phrase: "97-98."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
Processing 00000000.tx.149: [Full Text]

Phrase: "[Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1527021:Text [Intellectual Product]
   861   C1554111:Text [Idea or Concept]
   861   C1705606:Text [Intellectual Product]
   861   C3541382:Text [Intellectual Product]

Phrase: "]"

